Home / GLENMARK.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLENMARK.NS make money? Does GLENMARK.NS have pricing power? What's the Earnings Whisper? Will GLENMARK.NS profit more as the business scales? What is GLENMARK.NS's management track record? Is GLENMARK.NS's current price justified?

Glenmark Pharmaceuticals Limited

₹2226.7 +$200.50 (+9.90%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹2250.5

Day Range

₹2223.7₹2266.9

Year Range

₹1792.6₹2537.6

Market Cap

628.43B

AVG Volume

559.04K

Trailing/Forward PE

34.95/22.36

PEG ratio

-1.97

Dividend Yield

0.22%

Next Earnings Date

2026-11-06

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

GLENMARK.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	177.37B
26 Q4	169.83B
26 Q3	164.08B
26 Q2	159.26B
26 Q1	133.13B
25 Q4	132.92B
25 Q3	139.92B
25 Q2	130.8B
25 Q1	128.54B
24 Q4	130.11B

Net Income (INR) · TTM

GLENMARK.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	17.98B
26 Q4	13.62B
26 Q3	10.65B
26 Q2	10.1B
26 Q1	7.54B
25 Q4	10.47B
25 Q3	-1.76B
25 Q2	-8.75B
25 Q1	-13.11B
24 Q4	-15.02B

Operating Income (INR) · TTM

GLENMARK.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	35.9B
26 Q4	34.09B
26 Q3	23.6B
26 Q2	31.91B
26 Q1	31.4B
25 Q4	41.13B
25 Q3	47.76B
25 Q2	39.51B
25 Q1	36.51B
24 Q4	36.71B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Glenmark Pharmaceuticals Limited

Video analysis: GLENMARK.NS

News: GLENMARK.NS

Similar companies